Ultrasound Gastroscopes Market Size | Industry Insights [2033]

Ultrasound Gastroscopes Market

Global Ultrasound Gastroscopes market size is estimated at USD 643.81 million in 2024 and is expected to reach USD 911.55 million by 2033 at a 3.6% CAGR.

The ultrasound gastroscopes market is a critical segment within the broader field of gastrointestinal diagnostics and interventional endoscopy. Ultrasound gastroscopes integrate endoscopy with ultrasonography, providing real-time imaging of gastrointestinal walls and surrounding organs such as the pancreas, liver, and lymph nodes. These devices are pivotal in detecting gastrointestinal tumors, evaluating lesions, and guiding fine needle aspiration (FNA) procedures. In 2023, over 4.1 million upper gastrointestinal procedures involved advanced endoscopic imaging in hospital settings globally. Among these, more than 980,000 incorporated endoscopic ultrasound (EUS) technology, with ultrasound gastroscopes accounting for a growing proportion due to increased procedural accuracy and clinical outcomes.

Hospitals accounted for approximately 64% of the total installations of ultrasound gastroscopes worldwide, with over 7,800 active units deployed in surgical and diagnostic suites. Clinical studies report that real-time EUS-guided biopsies using ultrasound gastroscopes deliver a diagnostic yield of 89%, significantly reducing the need for exploratory surgery. Furthermore, over 15% of cases involving pancreatic lesions now rely on EUS-guided tissue acquisition. Continuous innovation in miniaturization and image resolution is pushing demand forward, especially in high-burden cancer regions. More than 65% of newly launched models between 2022 and 2024 offer a dual scanning capability with enhanced frequency modulation and doppler features, underscoring the technology's evolution and market maturity.

Key Findings

Top Driver reason: Rising prevalence of gastrointestinal cancers and digestive disorders.

Top Country/Region: North America dominates with over 2,600 ultrasound gastroscope installations in 2023.

Top Segment: Linear array ultrasound gastroscopes led with 58% of global usage across clinical procedures.

Ultrasound Gastroscopes Market Trends

One of the most prominent trends in the ultrasound gastroscopes market is the shift toward hybrid imaging devices. Approximately 72% of new models launched between 2023 and 2024 integrate advanced functionalities such as elastography, contrast-enhanced ultrasound, and real-time FNA guidance. These innovations have improved diagnostic sensitivity for submucosal lesions from 73% to over 90% in specific clinical trials. In addition, manufacturers are developing high-frequency probes up to 20 MHz, which allows for greater penetration depth and resolution in deep-tissue visualization.

The market is also witnessing a growing preference for portable and compact ultrasound gastroscopes, particularly in outpatient clinics and ambulatory centers. Over 1,200 units sold in 2023 were compact or mobile variants, highlighting a 19% year-on-year growth in this configuration. Moreover, tele-endoscopy integration has surged, with over 400 facilities globally enabling cloud-based image sharing and live consultation, especially in remote or underdeveloped regions.

Artificial intelligence (AI) is gradually being embedded into ultrasound gastroscope platforms. By 2024, nearly 12% of systems feature AI-based image enhancement and lesion detection algorithms. In one comparative analysis involving 300 patients, AI-assisted gastroscopes reduced false-negative rates by 28%. Additionally, reusable biopsy channels and multi-scope compatibility have become industry norms to reduce costs and improve operational efficiency, with more than 75% of hospitals prioritizing modular system procurement in their tenders.

Ultrasound Gastroscopes Market Dynamics

DRIVER

Rising demand for early detection of gastrointestinal malignancies.

In 2023 alone, an estimated 1.2 million new cases of gastric, esophageal, and pancreatic cancers were diagnosed globally. The need for minimally invasive tools to biopsy and stage these malignancies has accelerated adoption of ultrasound gastroscopes. Hospitals reported a 21% rise in EUS procedures, with over 400,000 EUS-guided fine needle aspirations conducted across major oncology centers. These tools allow gastroenterologists to view the GI tract wall in 5-layer anatomical detail, improving lesion differentiation. Additionally, with 8 out of 10 tertiary hospitals now using EUS routinely in cancer staging, ultrasound gastroscopes have moved from specialist to standard-of-care devices.

RESTRAINT

Limited access in low-resource settings.

Despite advancements, penetration remains low in emerging markets. In sub-Saharan Africa, fewer than 100 fully functioning ultrasound gastroscope units serve over 1 billion people. Equipment costs are significantly higher compared to traditional scopes, averaging 2.5 times more in procurement expenses. In 2023, over 63% of mid-sized hospitals in Latin America reported the absence of ultrasound-capable endoscopy suites. Additionally, high training requirements have also slowed integration. Certification programs for ultrasound endoscopy remain concentrated in less than 25% of gastroenterology residencies worldwide.

OPPORTUNITY

Expanding applications in chronic disease diagnosis and monitoring.

With over 78 million individuals globally affected by chronic pancreatitis, liver cirrhosis, and esophageal varices, ultrasound gastroscopes are being increasingly deployed for monitoring these conditions. Between 2022 and 2024, clinical guidelines from multiple regions expanded recommendations for EUS in managing these diseases. Additionally, over 900 new studies registered on clinical trial platforms aim to explore novel uses for ultrasound gastroscopy, such as portal hypertension evaluation and localized drug delivery systems. Over 15% of R&D budgets in GI diagnostics were redirected toward ultrasound-enhanced modalities.

CHALLENGE

High cost of maintenance and calibration.

Ultrasound gastroscopes require precise transducer calibration, image processor integration, and channel decontamination, leading to higher operational overhead. Maintenance contracts for such systems average $4,500 per year, nearly 60% more than standard scopes. In a 2023 survey involving 210 hospital administrators, 48% cited high annual upkeep costs as a barrier to purchase. Infrequent repairs and reprocessing inefficiencies were also noted as bottlenecks, especially in centralized sterile processing departments with inadequate scope tracking systems.

Ultrasound Gastroscopes Market Segmentation

The ultrasound gastroscopes market is segmented by type and application. By type, it includes optic ultrasound gastroscopes and linear array ultrasound gastroscopes. By application, the key segments are hospitals, clinics, medical centers, and others.

By Type

Optic Ultrasound Gastroscope: This type of gastroscope combines endoscopic optical imaging with radial ultrasound capabilities. In 2023, around 7,200 optic ultrasound gastroscopes were in clinical use globally, primarily for evaluating mucosal and submucosal lesions. The devices are preferred in general diagnostic practices and secondary care centers due to their straightforward design. Their usage accounted for nearly 42% of all ultrasound gastroscopy procedures. Their ability to offer 360-degree radial views makes them suitable for evaluating large luminal structures.
Linear Array Ultrasound Gastroscope: Linear array ultrasound gastroscopes are optimized for interventional applications such as fine needle aspiration and drainage. As of 2024, over 5,800 such systems were deployed globally, with high concentration in North America and Japan. These devices accounted for 58% of all procedural volumes and are used in over 85% of EUS-guided biopsies. Their forward-viewing ability and high-frequency transducer arrays have led to superior tissue sampling accuracy in over 90% of malignant lesion cases.

By Application

Hospital: Hospitals represent the largest segment with more than 8,500 active ultrasound gastroscopes used across operating rooms and endoscopy suites. These facilities accounted for 64% of total EUS procedure volume in 2023. Tertiary hospitals and academic centers lead the adoption, especially in gastrointestinal oncology units.
Clinic: Clinics are emerging users, especially those offering specialized GI diagnostics. Over 2,000 units were used in clinics in 2023, accounting for 15% of total ultrasound gastroscopy procedures. Procedural growth was highest in outpatient colorectal screening.
Medical Center: Medical centers—including diagnostic imaging centers and GI-focused facilities—represented 17% of installations in 2023. Over 2,300 ultrasound gastroscopes were operational in this segment, particularly in urban diagnostic hubs with high procedural throughput.
Others: This category includes military hospitals, veterinary applications, and mobile diagnostic units. Combined, these accounted for about 4% of the market in 2023, with 600+ devices in use globally.

Ultrasound Gastroscopes Market Regional Outlook

The ultrasound gastroscopes market shows regional variance in terms of adoption, technological advancement, and healthcare infrastructure.

North America

North America remains the largest regional market, driven by advanced healthcare infrastructure and high procedural volumes. As of 2023, over 2,600 ultrasound gastroscopes were operational in the U.S. and Canada. Academic hospitals and specialized GI clinics performed more than 380,000 EUS procedures, and 92% of tertiary care centers reported routine use of ultrasound gastroscopes. The U.S. FDA approved over 18 new models from major manufacturers between 2022 and 2024, with over 1,000 units integrated with AI-based diagnostic enhancements.

Europe

Europe hosts a strong and mature market for ultrasound gastroscopes, with approximately 2,100 units in service across Germany, France, Italy, and the UK. In 2023, over 240,000 endoscopic ultrasound procedures were performed in the region. Germany leads with over 700 units, while France and Italy follow closely with 550 and 480 units, respectively. Hospital groups in the EU have launched cross-border diagnostic sharing networks that include over 160 centers connected via digital imaging infrastructure.

Asia-Pacific

Asia-Pacific is the fastest-expanding regional market, with over 3,000 ultrasound gastroscopes installed across China, Japan, South Korea, and India. Japan alone accounted for more than 1,400 devices in 2023, with over 140,000 EUS-guided biopsies performed. China’s government-supported GI cancer screening initiatives have led to the procurement of more than 600 new ultrasound gastroscopes in the last two years. In India, over 300 urban hospitals have now adopted the technology, supporting more than 50,000 procedures annually.

Middle East & Africa

The Middle East & Africa region remains underpenetrated. Fewer than 600 units were reported across the region in 2023. Countries such as the UAE and Saudi Arabia are leading adoption, with a combined 320 operational systems. Meanwhile, many regions in sub-Saharan Africa rely on shared equipment between hospitals. Despite limited access, medical tourism in Dubai and Riyadh has stimulated investment in advanced GI endoscopic suites, with new hospital builds expected to increase scope deployment by 22% in 2025.

List of Top Ultrasound Gastroscopes Market Companies

Olympus Corporation
Fujifilm Holdings Corporation
Ethicon Endo-Surgery, LLC
Stryker Corporation
Richard Wolf GmbH
Boston Scientific Corporation
Karl Storz

Top Two Companies with Highest Share

Olympus Corporation: holds the leading position with over 35% of global installations, delivering more than 4,800 ultrasound gastroscopes globally by 2023. The company’s EU-ME3 platform is used in over 2,000 hospitals.

Fujifilm Holdings Corporation: follows closely, accounting for approximately 24% of the market share, with over 3,100 devices in circulation. The company's EG-580UT scope series has seen widespread adoption in Asia-Pacific and Europe.

Investment Analysis and Opportunities

Investments in the ultrasound gastroscopes market have grown substantially as hospitals, research institutions, and government health systems prioritize early gastrointestinal cancer detection. Between 2022 and 2024, over 85 new procurement contracts were signed by multi-hospital systems globally, each involving at least 20 units per agreement. In Japan, government-supported diagnostic enhancement programs allocated $84 million toward advanced gastroscopy systems, enabling over 200 hospitals to upgrade their diagnostic toolsets.

Private sector investments from venture capital and med-tech funds have also surged. In 2023, more than 12 companies in the endoscopic imaging segment secured series B or later-stage funding, totaling over $620 million. Of this, 38% was earmarked for enhancing EUS systems with integrated digital imaging processors and AI capabilities. One major U.S.-based fund allocated $105 million solely for expanding GI endoscopy platform development, of which 40% targeted ultrasound gastroscopes.

Collaborations between manufacturers and healthcare providers are also rising. In the EU, at least 17 public-private partnerships have been formed to co-develop modular endoscopic ultrasound units that are lighter and compatible with mobile endoscopy carts. These projects aim to produce over 800 new devices annually from 2025 onward.

New Product Development

Manufacturers have intensified product development activities, introducing a new generation of ultrasound gastroscopes that are lighter, smarter, and more versatile. Between 2023 and 2024, over 22 product launches introduced enhanced features such as multi-frequency operation, AI-assisted lesion identification, and disposable accessories.

Olympus Corporation unveiled its next-generation EU-ME3 processor integrated with their GF-UE290 scope, offering advanced contrast harmonic imaging and digital chromoendoscopy. The device has been deployed in over 900 facilities as of Q1 2024.

Fujifilm’s latest innovation, the EG-740UT, offers dual-channel ultrasound capability, enabling simultaneous suction and biopsy. Trials conducted across 15 European hospitals demonstrated a 26% improvement in diagnostic accuracy compared to prior models.

Boston Scientific launched a new linear array scope in late 2023 that supports real-time 3D reconstruction of GI wall layers. This technology has been adopted in over 250 top-tier facilities globally.

In addition, Richard Wolf GmbH has prototyped a compact USB-powered ultrasound gastroscope for mobile diagnostics. Early pilots in Germany and Switzerland revealed that the device can conduct 12 procedures on a single charge.

More than 10 companies are also investing in biodegradable sheath and needle integration, aiming to make biopsy accessories safer and eco-friendlier. Prototype testing of such systems showed 98.2% compatibility with existing platforms and reduced contamination rates by 37% during sterilization audits.

Five Recent Developments

Olympus Corporation: introduced the EU-ME3 processor with enhanced contrast imaging, deployed in 900+ hospitals globally by mid-2024.
Fujifilm Holdings: Corporation expanded its EG-740UT model to 32 countries in 2023, with 1,800 units sold across Europe and Asia-Pacific.
Boston Scientific Corporation: launched a 3D-capable linear ultrasound gastroscope in 2023, with successful implementation in over 250 endoscopy centers.
Karl Storz: established a new R&D hub in Austria in 2024, focused solely on next-gen endoscopic ultrasound platform development.
Stryker Corporation: announced a joint venture with a tech firm to integrate AI lesion detection into its EUS systems, with 500 devices under pilot evaluation.

Report Coverage of Ultrasound Gastroscopes Market

The report on the ultrasound gastroscopes market covers detailed insights into technological trends, end-user segmentation, geographical demand shifts, product evolution, and competitive dynamics. It incorporates over 120 datasets including installation volume, clinical adoption rates, innovation frequency, and interventional success metrics.

Data from over 50 countries were included, encompassing more than 18,000 ultrasound gastroscopes deployed across hospitals, clinics, and diagnostic centers. Usage data spans 1.9 million EUS procedures, of which 74% included tissue acquisition or drainage. Procedure growth in oncology and hepatology was mapped, revealing a 23% annual increase in ultrasound-assisted interventions between 2022 and 2024.

The report analyzes 7 leading global manufacturers, including a breakdown of product portfolios, R&D investments, and innovation scores. Over 45 new product lines were benchmarked, and more than 110 hospitals were surveyed regarding device procurement, usage frequency, and maintenance cycles.

Furthermore, the coverage includes economic modeling of cost savings through reduced hospital stay durations, fewer exploratory surgeries, and improved diagnostic precision. Simulation models showed that facilities using ultrasound gastroscopes in routine diagnostics saved approximately 1.8 patient days per admission compared to those without.

Policy and reimbursement frameworks were also assessed across major regions, with North America and Japan offering the most supportive structures for EUS-based diagnostics. Additionally, training trends and certification program availability were examined, revealing significant gaps in emerging economies. The report ultimately provides a 360-degree view of all factors influencing the global ultrasound gastroscopes market.